EV/EBITDA
1.73
-0.01-0.57%
13 min ago
Summary:
PharmaCyte Biotech EV/EBITDA is currently 1.73, with a fall of -0.01 (-0.57%) during the most recent trading day. Over the past year, it has dropped by -7.51 (-81.28%). PMCB EV/EBITDA is now -86.13% below its all-time high of 12.47.PMCB EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PMCB EV/EBITDA Performance
| PeriodPeriod | EV/EBITDAEV/EBITDA |
|---|---|
| todaytoday | -0.6% |
| 1 m1 month | +0.6% |
| 3 m3 months | -47.3% |
| 6 m6 months | -66.2% |
| ytdytd | -5.5% |
| 1 y1 year | -81.3% |
| 5 y5 years | +111.8% |
PMCB EV/EBITDA High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | 1.92 | -9.9% | 1.65 | +4.8% |
| 3 m | 3 months | 3.70 | -53.2% | 1.38 | +25.4% |
| 6 m | 6 months | 5.39 | -67.9% | 1.38 | +25.4% |
| 1 y | 1 year | 9.34 | -81.5% | 1.38 | +25.4% |
| 3 y | 3 years | 12.47 | -86.1% | 1.38 | +25.4% |
| 5 y | 5 years | 12.47 | -86.1% | -23.45 | +107.4% |
| alltime | all time | 12.47 | -86.1% | -61.09 | +102.8% |
PharmaCyte Biotech EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | 1.73(-5.5%) |
| 2024 | 1.83(-80.2%) |
| 2023 | 9.23(+142.3%) |
| 2022 | 3.81(-59.7%) |
| 2021 | 9.45(-361.0%) |
| 2020 | -3.62(-75.0%) |
| Date | Value |
|---|---|
| 2019 | -14.50(+97.0%) |
| 2018 | -7.36(-18.3%) |
| 2017 | -9.01(-65.7%) |
| 2016 | -26.23(+574.3%) |
| 2015 | -3.89(-50.3%) |
| 2014 | -7.82(+40.1%) |
| 2013 | -5.58 |
FAQ
- What is PharmaCyte Biotech EV/EBITDA?
- What is the all time high EV/EBITDA for PharmaCyte Biotech?
- What is PMCB EV/EBITDA year-to-date change?
- What is PharmaCyte Biotech EV/EBITDA year-on-year change?
What is PharmaCyte Biotech EV/EBITDA?
The current EV/EBITDA of PMCB is 1.73
What is the all time high EV/EBITDA for PharmaCyte Biotech?
PharmaCyte Biotech all-time high EV/EBITDA is 12.47
What is PMCB EV/EBITDA year-to-date change?
PharmaCyte Biotech EV/EBITDA has changed by -0.10 (-5.46%) since the beginning of the year
What is PharmaCyte Biotech EV/EBITDA year-on-year change?
Over the past year, PMCB EV/EBITDA has changed by -7.51 (-81.28%)